Companies · Other Health Care

Dror Ortho-Design, Inc.

JERUSALEM · Other Health Care

Diligence memoA one-page analyst read on Dror Ortho-Design, Inc. — recommendation, valuation, rhythm, risks.
$72.9M
Total raised · real
3
Rounds
6.2×
Latest step-up
Top 7%
Sector rank · raised
Series C
Latest stage · inferred · Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Dror Ortho-Design, Inc. looks fair against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.97× the median modeled value of Series C Other Health Care companies in 2022–2024 (47 peers) — value vs value, same stage and era.
  • Within the normal band (97% of peer median) for its niche.
At-risk
  • Last raise 2.9 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Dror Ortho-Design, Inc. is one of 5377 Other Health Care companies tracked from JERUSALEM. By capital raised it ranks among the largest (ahead of 94% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
39
Investors (latest)
2023-08-14
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BPre-Seed · 2008-12-04 Raised $600K (real) Modeled valuation $18M (est)$600K$18MPre-Seed2008Series A · 2011-03-31 Raised $10M (real) Modeled valuation $203M (est)$10M$203MSeries A2011Series C · 2023-08-14 Raised $62M (real) Modeled valuation $638M (est)$62M$638MSeries C2023+$10M+$62MCumulative $73M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$600K · 2008
Series A$10.1M · 2011no Seed on file
Series C$62.2M · 2023no Series B on file

Stages are modeled from round size (public records carry no series label). No record for: Seed, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 60%.

Modeled valuation trajectory
$638.1M
Base estimate est.
$226.1M
Conservative case
$1.1B
Upside case
$414.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $18.5M · 2008-12-042008Series A · modeled $203.4M · 2011-03-31Series C · modeled $638.1M · 2023-08-142023
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.29×/yr
Annual markup
1.48×/yr upside case
2.9 yr
Elapsed time used
2.9 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
88 mo
Avg between rounds
$5.0M/yr
Capital velocity
17.6 yr
On record since
2008
First round
3
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 30× above median
This company$72.9M
Sector median$2.4M
Latest round — vs other Series C rounds in sector (real $, this stage) 1.4× above median
This company$62.2M
Sector median$45.9M
Modeled value — vs sector median (estimate, all stages) 29× above median
This company$638.1M
Sector median$22.1M

Raised more than 94% of sector peers (real $). Modeled value above 94% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #26 of 47.

This companyCohort peer
$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Gravie, Inc. · Series C Raised $160.7M · modeled $1.3B (est)EmpowerMe Holdings, LLC · Series C Raised $96.6M · modeled $1.3B (est)Color Holdings, L.P. · Series C Raised $90.9M · modeled $1.1B (est)RSR Senior Residences, LLC · Series C Raised $73.7M · modeled $1.1B (est)Gynesonics, Inc · Series C Raised $299.1M · modeled $1.0B (est)Hello Heart Inc. · Series C Raised $127.0M · modeled $1.0B (est)Beta Bionics, Inc · Series C Raised $277.5M · modeled $1.0B (est)BioDerm Holdings, LP · Series C Raised $130.9M · modeled $1.0B (est)Kindbody, Inc. · Series C Raised $95.6M · modeled $875.1M (est)Drconsulta Ltd. · Series C Raised $140.1M · modeled $837.3M (est)Fountain Life, LLC · Series C Raised $103.9M · modeled $828.2M (est)TherapyMatch, Inc. · Series C Raised $100.0M · modeled $809.2M (est)Dror Ortho-Design, Inc. (this company) Raised $72.9M · modeled $638.1M (est)Dror Ortho-Design, Inc.
CompanyStageRaised · realValue · estvs peer med.
Gravie, Inc.Series C$160.7M$1.3B2.04×
EmpowerMe Holdings, LLCSeries C$96.6M$1.3B1.92×
Color Holdings, L.P.Series C$90.9M$1.1B1.75×
RSR Senior Residences, LLCSeries C$73.7M$1.1B1.71×
Gynesonics, IncSeries C$299.1M$1.0B1.58×
Hello Heart Inc.Series C$127.0M$1.0B1.54×
Beta Bionics, IncSeries C$277.5M$1.0B1.54×
BioDerm Holdings, LPSeries C$130.9M$1.0B1.53×
Kindbody, Inc.Series C$95.6M$875.1M1.33×
Drconsulta Ltd.Series C$140.1M$837.3M1.28×
Fountain Life, LLCSeries C$103.9M$828.2M1.26×
TherapyMatch, Inc.Series C$100.0M$809.2M1.23×
Dror Ortho-Design, Inc. this companySeries C$72.9M$638.1M0.97×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$600K2008-12-04$3.3M$18.5M85%
Series A$10.1M2011-03-31$45.8M$203.4M85%
Series C$62.2M2023-08-14$414.7M$638.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$600K2008-12-04
    • First recorded raise — entered as Pre-Seed.
  2. Series A$10.1M2011-03-31
    • Raised again after 28 mo — slower than the ~14 mo sector norm.
    • Round 16.8× larger than the prior — scaling up.
    • 59 investors on this round.
  3. Series C$62.2M2023-08-14
    • Raised again after 148 mo — slower than the ~14 mo sector norm.
    • Round 6.2× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 39 investors on this round.
Intelligence
2030 ~Q4
Modeled next raise · ~88mo cadence
$186.6M
Modeled next size est.range $121.3M$298.6M
6.2×
Last step-up
$5.0M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Chaim Hurvitz5 other2023-08
Tom Anderson4 other2011-03
Moshe Shvets1 other2023-08
Thomas G. Anderson1 other2008-12
V. Gerald Grafe1 other2008-12
Yehuda Englander1 other2023-08
Brian Gerald Long2011-03
Chaim Ravad2023-08
Eliyahu Haddad2023-08
Jan Gerald Richardson2011-03
Marvin Maslow2008-12
Ryan Gerald Christoff2011-03
Shannon Gerald Vissman2011-03
Walter Aviles2008-12
Registry & provenance

Dror Ortho-Design, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1282980
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Dror Ortho-Design LtdOther Health CareSeed$3.0M$40.2Mnetwork3 shared operators · same sector
Nucleus Radiopharma, Inc.Other Health CareSeries C$72.1M$662.9Msame sector · same stage
iSchemaView, Inc.Other Health CareSeries C$75.0M$783.0Msame sector · same stage
R3 Vascular Inc.Other Health CareSeries C$75.2M$621.1Msame sector · same stage
OneOncology Management Holdco, LLCOther Health CareSeries C$75.2M$807.9Msame sector · same stage
Spinal Modulation IncOther Health CareSeries C$76.3M$1.0Bsame sector · same stage
RMX Holdco, Inc.Other Health CareSeries C$76.6M$720.5Msame sector · same stage
4Paws Dx, Inc.Other Health CareSeries C$69.1M$780.4Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Dror Ortho-Design LtdOther Health CareSeed$40.2M98%
ALM Ortho IncOther Health CarePre-Seed$579K89%
Orthoevidence Inc.Other Health CarePre-Seed$30.8M88%
Adaptable Ortho Innovations LLCOther Health CarePre-Seed$7.4M88%
N H Spine & Ortho, Inc.Other Health CarePre-Seed$22.5M87%
Orthobrain, Inc.Other Health CareSeries A$112.5M87%
OrthoPreserve, Inc.Other Health CarePre-Seed$327K87%
Ortho Kinematics, Inc.Other Health CareSeries B$9.1M86%
Frequently asked
How much funding has Dror Ortho-Design, Inc. raised?
Dror Ortho-Design, Inc. has raised approximately $72.9M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Dror Ortho-Design, Inc.'s estimated valuation?
Provath's modeled valuation for Dror Ortho-Design, Inc. is approximately $638.1M (modeled range $226.1M–$1.1B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Dror Ortho-Design, Inc. at?
Dror Ortho-Design, Inc.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Mon Aug 14.
What does Dror Ortho-Design, Inc. do and where is it based?
Dror Ortho-Design, Inc. operates in the Other Health Care sector, based in JERUSALEM.
Explore related

See where Dror Ortho-Design, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Dror Ortho-Design, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.